Piecing Together Aminergic Polypharmacology
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Schneider L, Dagerman K, Insel P
. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005; 294(15):1934-43.
DOI: 10.1001/jama.294.15.1934.
View
2.
Meltzer H, Matsubara S, Lee J
. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther. 1989; 251(1):238-46.
View
3.
Roth B
. Molecular pharmacology of metabotropic receptors targeted by neuropsychiatric drugs. Nat Struct Mol Biol. 2019; 26(7):535-544.
PMC: 6613815.
DOI: 10.1038/s41594-019-0252-8.
View
4.
Roth B, Sheffler D, Kroeze W
. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov. 2004; 3(4):353-9.
DOI: 10.1038/nrd1346.
View
5.
Sumiyoshi T, Park S, Jayathilake K, Roy A, Ertugrul A, Meltzer H
. Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study. Schizophr Res. 2007; 95(1-3):158-68.
DOI: 10.1016/j.schres.2007.06.008.
View